Mazor Robotics Ltd  

(Public, OTCMKTS:MZRTF)   Watch this stock  
Find more results for PINK:MZRTF
+0.01 (0.17%)
Feb 27 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 6.07 - 6.07
52 week 4.73 - 12.64
Open 6.07
Vol / Avg. 1,126.00/864.00
Mkt cap 1.00B
P/E     -
Div/yield     -
EPS -1.26
Shares 42.13M
Beta 2.14
Inst. own     -
May 6, 2015
Q1 2015 Mazor Robotics Ltd Earnings Release (Estimated) Add to calendar
Mar 10, 2015
Mazor Robotics Ltd at Barclays Healthcare Conference - 1:35PM EDT - Add to calendar
Feb 18, 2015
Q4 2014 Mazor Robotics Ltd Earnings Release
Feb 18, 2015
Q4 2014 Mazor Robotics Ltd Earnings Call - Webcast
Dec 31, 2014
Mazor Robotics Ltd Annual Shareholders Meeting

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -63.59% -102.73%
Operating margin -57.51% -34.67%
EBITD margin - -31.62%
Return on average assets -23.75% -44.52%
Return on average equity -26.59% -53.38%
Employees 113 -
CDP Score - -


7 HaEshel St. Caesarea Industrial Park South PO Box 3104
+972-4-6187100 (Phone)
+972-4-6187111 (Fax)

Website links


Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.

Officers and directors

Jonathan Adereth Chairman of the Board
Age: 66
Ori Hadomi Chief Executive Officer, Director
Age: 46
Sharon Levita Chief Financial Officer, Secretary
Age: 45
Eliyahu Zahavi Chief Operating Officer
Age: 58
Moshe Shoham Chief Technology Officer
Age: 61
Avraham Posen Vice President of International Sales
Age: 47
Sandra Adzic Vice President of International Sales
Doron Dinstein Chief Medical Officer
Age: 42
Michael Berman Director
Age: 56
Sarit Sukari Soccary Ben-Yochanan Director
Age: 41